Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mid-dermal elastolysis

J C Sterling1, N Coleman, R J Pye

  • 1Department of Dermatology, Addenbrooke's Hospital, Cambridge, U.K.

The British Journal of Dermatology
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progress in targeting the untouchables: emerging approaches for hard-to-drug cancer targets.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Corrigendum to "Comparative Analysis of Radiotherapy Linear Accelerator Downtime and Failure Modes in the UK, Nigeria and Botswana" [Clinical Oncology 32 (2020) e111-e118].

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lung cancer.

ESMO open·2021
Same author

An unusual case of longstanding mammary Paget disease presenting with reticulated skin changes.

Clinical and experimental dermatology·2021
Same author

Polyomaviruses - be aware, be very aware.

The British journal of dermatology·2019
Same journal

Shallow Cuts, Deeper Issues: The Primacy of Deep Margins in Cutaneous Squamous Cell Carcinoma.

The British journal of dermatology·2026
Same journal

Management Patterns and Repigmentation Outcomes in Pediatric Segmental Versus Non-segmental Vitiligo: A Single-center Retrospective Study (2015-2024).

The British journal of dermatology·2026
Same journal

Quality-of-Life Measurement in Migrants and Other Vulnerable Groups: Experience with Skindex-16 in Malta and Lebanon.

The British journal of dermatology·2026
Same journal

Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

The British journal of dermatology·2026
Same journal

Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

The British journal of dermatology·2026
Same journal

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

The British journal of dermatology·2026
See all related articles

Mid-dermal elastolysis involves mild dermal inflammation and the destruction of elastic fibers. This study suggests a specific immune response contributes to the condition, offering new insights into its cause.

Area of Science:

  • Dermatology
  • Immunology
  • Pathology

Background:

  • Mid-dermal elastolysis is a rare skin condition characterized by the loss of elastic fibers in the mid-dermis.
  • The exact cause of mid-dermal elastolysis is currently unknown.
  • Previous studies have not extensively explored the role of inflammation in this condition.

Observation:

  • A case of mid-dermal elastolysis presented with mild but discernible dermal inflammation.
  • Inflammatory areas within the affected skin showed distinct characteristics.
  • These characteristics suggested an active immune process occurring in the dermis.

Findings:

  • The inflammatory response in the observed case exhibited features of a specific immune reaction.
  • Key immune accessory molecules were found to be induced in the inflamed dermal areas.

Related Experiment Videos

  • These findings point towards an immune-mediated mechanism in the pathogenesis of mid-dermal elastolysis.

    • Implications:

    • The identification of an immune response in mid-dermal elastolysis may help elucidate its unknown etiology.
    • Understanding the role of specific immune molecules could lead to targeted therapeutic strategies.
    • Further research into the immunological aspects of this condition is warranted.